C57BL/6JCya-Csgalnact1em1flox/Cya
Common Name:
Csgalnact1-flox
Product ID:
S-CKO-07724
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Csgalnact1-flox
Strain ID
CKOCMP-234356-Csgalnact1-B6J-VB
Gene Name
Product ID
S-CKO-07724
Gene Alias
4732435N03Rik; CSGalNAcT-1
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
8
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Csgalnact1em1flox/Cya mice (Catalog S-CKO-07724) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000078350
NCBI RefSeq
NM_172753
Target Region
Exon 5
Size of Effective Region
~1.1 kb
Detailed Document
Overview of Gene Research
Csgalnact1, which encodes chondroitin sulfate N-acetylgalactosaminyltransferase 1, is a key enzyme in the biosynthesis of sulfated glycosaminoglycans chondroitin and dermatan sulfate [2,3,6]. It initiates chondroitin sulfate (CS) chain biosynthesis on the GAG-protein linker region tetrasaccharide [6]. CS, a major component of proteoglycans in the extracellular matrix, is involved in numerous biological processes, such as synaptic plasticity in the brain and the synthesis of connective tissues [1,4].
Gene knockout mouse models have provided crucial insights into Csgalnact1's functions. T1KO mice (lacking Csgalnact1) show extensive axon regeneration following spinal cord injury and loss of onset of ocular dominance plasticity, suggesting its importance in neuronal plasticity and axon regeneration [1]. Biochemically, the loss of this enzyme reduces CS amount by about 50% in various brain regions, leading to abnormal behaviors in tests like the open-field test, acoustic startle response, and social preference, indicating its role in regulating CS-dependent perineuronal nets (PNNs) [4]. In addition, CSGalNAcT1-KO mice have milder symptoms in experimental autoimmune encephalomyelitis compared to wild-type mice, suggesting CS's contribution to the induction phase of this disease [5]. Diabetic T1KO mice are more resistant to diabetic neuropathy, with more stable pericyte-endothelial cell interactions and less up-regulated Smad2/3 phosphorylation in the transforming growth factor β signaling pathway [7]. In humans, biallelic loss-of-function mutations in Csgalnact1 cause a mild skeletal dysplasia with features like joint hypermobility, axial malalignment, and advanced bone age [2,3,6].
In conclusion, Csgalnact1 plays essential roles in neuronal plasticity, axon regeneration, immune-related neurological diseases, and skeletal development. The study of Csgalnact1 KO mouse models has significantly advanced our understanding of its functions in these disease-related biological processes, providing potential insights for treating related disorders.
References:
1. Igarashi, Michihiro, Takeuchi, Kosei, Sugiyama, Sayaka. 2017. Roles of CSGalNAcT1, a key enzyme in regulation of CS synthesis, in neuronal regeneration and plasticity. In Neurochemistry international, 119, 77-83. doi:10.1016/j.neuint.2017.10.001. https://pubmed.ncbi.nlm.nih.gov/28987564/
2. Meyer, R, Schacht, S, Buschmann, L, Kurth, I, Elbracht, M. 2019. Biallelic CSGALNACT1-mutations cause a mild skeletal dysplasia. In Bone, 127, 446-451. doi:10.1016/j.bone.2019.07.016. https://pubmed.ncbi.nlm.nih.gov/31325655/
3. Mizumoto, Shuji, Janecke, Andreas R, Sadeghpour, Azita, Yamada, Shuhei, Vodopiutz, Julia. 2019. CSGALNACT1-congenital disorder of glycosylation: A mild skeletal dysplasia with advanced bone age. In Human mutation, 41, 655-667. doi:10.1002/humu.23952. https://pubmed.ncbi.nlm.nih.gov/31705726/
4. Yoshioka, Nozomu, Miyata, Shinji, Tamada, Atsushi, Takeuchi, Kosei, Igarashi, Michihiro. 2017. Abnormalities in perineuronal nets and behavior in mice lacking CSGalNAcT1, a key enzyme in chondroitin sulfate synthesis. In Molecular brain, 10, 47. doi:10.1186/s13041-017-0328-5. https://pubmed.ncbi.nlm.nih.gov/28982363/
5. Inada, Rino, Miyamoto, Katsuichi, Tanaka, Noriko, Igarashi, Michihiro, Kusunoki, Susumu. . Chondroitin sulfate N-acetylgalactosyltransferase-1 knockout shows milder phenotype in experimental autoimmune encephalomyelitis than in wild type. In Glycobiology, 31, 260-265. doi:10.1093/glycob/cwaa072. https://pubmed.ncbi.nlm.nih.gov/32839819/
6. Vodopiutz, Julia, Mizumoto, Shuji, Lausch, Ekkehart, Sugahara, Kazuyuki, Janecke, Andreas R. 2016. Chondroitin Sulfate N-acetylgalactosaminyltransferase-1 (CSGalNAcT-1) Deficiency Results in a Mild Skeletal Dysplasia and Joint Laxity. In Human mutation, 38, 34-38. doi:10.1002/humu.23070. https://pubmed.ncbi.nlm.nih.gov/27599773/
7. Ishiguro, Hajime, Ushiki, Takashi, Honda, Atsuko, Igarashi, Michihiro, Sone, Hirohito. 2024. Reduced chondroitin sulfate content prevents diabetic neuropathy through transforming growth factor-β signaling suppression. In iScience, 27, 109528. doi:10.1016/j.isci.2024.109528. https://pubmed.ncbi.nlm.nih.gov/38595797/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen